Aberrant expression of AKR1C1 has been reported for ovarian cancer tissues [46] and breast cancer cells [47], and studies have shown the crucial role of AKR1C1 in progesterone signaling [48]. The gene discussed is AKR1C1; the disease is breast carcinoma.